MIGLIORE, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 468
EU - Europa 232
AS - Asia 73
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 775
Nazione #
US - Stati Uniti d'America 464
IE - Irlanda 124
CN - Cina 37
IT - Italia 30
TR - Turchia 26
DE - Germania 19
UA - Ucraina 18
CZ - Repubblica Ceca 16
FI - Finlandia 6
GB - Regno Unito 6
SG - Singapore 5
CA - Canada 4
RU - Federazione Russa 4
BE - Belgio 3
IN - India 3
VN - Vietnam 2
AU - Australia 1
EU - Europa 1
FR - Francia 1
ME - Montenegro 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
Totale 775
Città #
Chandler 136
Dublin 124
Jacksonville 73
New York 36
Izmir 24
Los Angeles 20
Lawrence 15
Princeton 15
Nanjing 13
Olomouc 13
Ashburn 12
Wilmington 11
Boardman 10
L'aquila 10
Ann Arbor 8
Nanchang 7
San Mateo 7
Rome 6
Singapore 5
Falls Church 4
Lappeenranta 4
Brno 3
Brussels 3
Changchun 3
Des Moines 3
Pune 3
Toronto 3
Villa Carcina 3
Aquila 2
Beijing 2
Berlin 2
Chions 2
Dearborn 2
Dong Ket 2
Fairfield 2
Fremont 2
Hebei 2
Mountain View 2
Pescara 2
Seattle 2
Shanghai 2
Verona 2
Volgograd 2
Amsterdam 1
Bremen 1
Cedar Knolls 1
Changsha 1
Cleveland 1
Frankfurt am Main 1
Hangzhou 1
Houston 1
Jiaxing 1
Katowice 1
Kunming 1
L’Aquila 1
Manchester 1
Markham 1
Melbourne 1
Milan 1
Montesilvano Marina 1
Moscow 1
Podgorica 1
Rostov-on-don 1
San Francisco 1
Shenyang 1
Stockholm 1
Tappahannock 1
Tianjin 1
Woodbridge 1
Zhengzhou 1
Totale 631
Nome #
Executive functioning in relapsing-remitting Multiple Sclerosis patients without cognitive impairment: a task switching protocol. 76
CM-Pf deep brain stimulation and the long term management of motor and psychiatric symptoms in a case of Tourette syndrome 58
Task-switching abilities in pre-manifest Huntington's disease subjects 50
Relationship among diffusion tensor imaging, EEG activity and cognitive status in Mild Cognitive Impairment and Alzheimer’s Disease patients. 50
Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability 49
Counterfactual thinking in moral judgement: an experimental study 48
Emotional processing in RRMS patients: Dissociation between behavioural and neurophysiological response 48
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 46
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache 45
Safer attitude to risky decision-making in premanifest Huntington’s disease subjects 44
Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study 44
Moral Judgment and Empathic/Deontological Guilt 39
Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment 39
Task-switching abilities in episodic and chronic migraine 37
Psychopathological profile of medication overuse headache patients, drug assumption and degree of disability 35
Abnormal visual scanning and impaired mental state recognition in pre-manifest Huntington disease 14
The validation of the Italian version of multiple sclerosis neuropsychological screening questionnaire in Huntington’s disease 9
Correction to: Task-switching abilities in episodic and chronic migraine (Neurological Sciences, (2022), 43, 6, (3803-3810), 10.1007/s10072-021-05837-4) 8
“Spazio Huntington”: Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats 6
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments 6
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 6
Migraineurs’ psychological traits do not influence response to erenumab 6
Emotional atypical arousal ratings for unpleasant stimuli in patients with Parkinson's disease 6
Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon? 5
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease 5
Effects of stimulus-related variables on mental states recognition in Huntington's disease. 5
Quality of life, health-related quality of life, and associated factors in Huntington’s disease: a systematic review 5
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire (Neurological Sciences, (2021), 42, 11, (4583-4589), 10.1007/s10072-021-05141-1) 5
Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease 5
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy. 4
Correction to: Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease (Journal of Neurology, (2020), 267, 5, (1527-1535), 10.1007/s00415-020-09730-6) 4
Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease 4
Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson’s and Huntington’s diseases 4
GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: Association hypothesis for an uncommon genetic variant 4
Association of K832R and R952K SNPs of Wilson's Disease Gene with Alzheimer's Disease 3
Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease 3
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population 3
Prodromal Cognitive Changes as a Prognostic Indicator of Forthcoming Huntington's Disease Severity: A Retrospective Longitudinal Study 3
Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease 3
Exploring emotion regulation and emotion recognition in people with presymptomatic Huntington's disease: the role of emotional awareness 2
Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: Evidence from a new Stroop task 2
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 2
Resting-state connectivity and modulated somatomotor and default-mode networks in Huntington disease 2
Development and psychometric testing of the care dependence perception questionnaire 2
Sleep Quality and Related Clinical Manifestations in Huntington Disease 2
Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease 2
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's Disease 2
Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis 2
Brain plasticity effects of neuromodulation against multiple sclerosis fatigue. 1
Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis 1
Totale 854
Categoria #
all - tutte 5.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 16 0 8 0 0 8 15 1 9 0 0 9
2020/202176 1 11 2 9 9 2 10 1 12 0 17 2
2021/202275 1 0 0 1 1 4 3 5 5 1 15 39
2022/2023351 23 29 8 38 17 42 2 26 150 1 10 5
2023/2024200 10 3 3 35 18 54 3 2 2 20 9 41
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 854